Carrolee Barlow's Insider Trades & SAST Disclosures

Carrolee Barlow's most recent trade in Supernus Pharmaceuticals Inc was a trade of 5,369 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 22, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Feb 2025 5,369 0 - - Restricted Stock Units
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2025 5,369 22,570 (0%) 0% 0 Common Stock
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2025 7,296 7,296 - - Director Stock Option (Right to Buy)
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2025 4,475 4,475 - - Restricted Stock Unit
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Feb 2024 3,886 0 - - Restricted Stock Units
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2024 3,886 17,201 (0%) 0% 0 Common Stock
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 8,252 8,252 - - Director Stock Option (Right to Buy)
Supernus Pharmaceuticals Inc
Barlow Carrolee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2024 5,369 5,369 - - Restricted Stock Units
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 6,293 6,293 - - Director Stock Option (Right to Buy)
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2023 3,886 3,886 - - Restricted Stock Units
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Feb 2023 3,882 0 - - Restricted Stock Units
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2023 3,882 13,315 (0%) 0% 0 Common Stock
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 6,847 6,847 - - Director Stock Option (Right to Buy)
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 3,882 3,882 - - Restricted Stock Units
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2022 4,222 9,433 (0%) 0% 0 Common Stock
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Sale or transfer of securities back to the company at price $ 0.00 per share. 19 Feb 2022 4,222 0 - - Restricted Stock Units
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2021 7,365 7,365 - - Director Stock Option (Right to Buy)
Supernus Pharmaceuticals Inc
Carrolee Barlow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2021 4,222 4,222 - - Restricted Stock Units
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades